Arena Capital Advisors, LLC- CA - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 69 filers reported holding BIOTECH ACQUISITION COMPANY in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Arena Capital Advisors, LLC- CA ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$3,029,970
+1.7%
300,0000.0%1.65%
+83.0%
Q3 2022$2,978,000
+0.3%
300,0000.0%0.90%
+20.5%
Q2 2022$2,970,000
+0.4%
300,0000.0%0.75%
+67.0%
Q1 2022$2,958,000
+0.2%
300,0000.0%0.45%
+65.1%
Q4 2021$2,952,000
+1.0%
300,0000.0%0.27%
+17.7%
Q3 2021$2,922,000
+210.5%
300,000
+208.4%
0.23%
+196.2%
Q2 2021$941,00097,2720.08%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q4 2022
NameSharesValueWeighting ↓
RiverPark Advisors, LLC 799,001$8,069,9103.84%
Corbin Capital Partners, L.P. 928,124$9,373,9602.85%
Arena Capital Advisors, LLC- CA 300,000$3,029,9701.65%
RPO LLC 359,009$3,625,9551.24%
Alpha Wave Global, LP 532,570$5,378,9570.98%
MMCAP International Inc. SPC 599,321$6,053,0820.61%
GLAZER CAPITAL, LLC 2,283,910$23,0670.60%
GRITSTONE ASSET MANAGEMENT LLC 39,247$396,3910.50%
CVI Holdings, LLC 292,563$2,954,8860.38%
FIR TREE CAPITAL MANAGEMENT LP 635,837$6,421,9540.33%
View complete list of BIOTECH ACQUISITION COMPANY shareholders